The Centers for Medicare and Medicaid Services must recalculate Anthem Blue Cross and Blue Shield of Georgia’s Medicare Advantage star ratings, a federal court ruled Friday in a win for Elevance Health, reported Modern Healthcare’s Nona Tepper.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health price target raised to $646 from $621 at BofA
- Early notable gainers among liquid option names on May 31st
- Elevance Health price target raised to $631 from $628 at JPMorgan
- Elevance Health initiated with an Outperform at Baird
- UnitedHealth slides after warning on âdisturbanceâ ahead in Medicaid business